Delivery Order SPE2DB25D3017-SPE2DB25FVHWG

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with a ceiling value of $2,675.70 and a period of performance through June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRILINTA 90 MG TABLET 60S, a medication, with a ceiling value of $1,928.55 and a period of performance through May 6, 2025. The contract was awarded on May 5, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRILINTA 90 MG TABLET 60S, a cardiovascular medication, with a ceiling value of $1,301.55 and a completion date of January 13, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,371.23, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,189,838 units of BRILINTA 90 MG TABLET 60S, a prescription medication, with a ceiling value of $2,723.35. The contract has a completion date of May 9, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRILINTA 90 MG TABLET 60S medication, with a ceiling value of $1,272.17 and a completion date of February 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRILINTA 90 MG TABLET 60S. The contract has a ceiling value of $1,383.90 and is a Firm Fixed Price contract. The ultimate completion date is July 24, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,957,226 units of the medication BRILINTA 90 MG TABLET 60S, with a firm fixed price ceiling value of $2,663.89. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRILINTA 60 MG TABLET 60S, a prescription medication. The contract has a ceiling value of $1,664.52 and runs through February 6, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,664.52, is for the delivery of BRILINTA 90 MG TABLET 60S, a cardiovascular medication. The contract has a firm fixed price pricing type and has an ultimate completion date of January 9, 2025. This award is not associated with a set-aside designation....
  • SPE2DB25D3017
    Indefinite Delivery Contract
  • SPE2DB25D3017-SPE2DB25FVHWG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BRILINTA 90 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with a ceiling value of $3,518.92 and a performance period through April 28, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This contract is not designated as a set-aside.

Generated 7/25/25, 11:32 AM